medical-devices is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Alcon, the most common co-covered peer. They are better corroborated than the beat average, carrying 5 original sources each against 3.1 for the same window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about JBS USA
medical-devices is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Alcon, the most common co-covered peer. They are better corroborated than the beat average, carrying 5 original sources each against 3.1 for the same window. At 6, the average consequence score sits below the same-window beat average of 6.3. JBS USA appears in 1 tracked Healthcare story from March 17, 2026.
Stories tracked
1
Sources per story
5
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 34 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering JBS USA. Shared-story counts are live from our verified record — not editorial picks.
Alcon has officially terminated its merger agreement with LENSAR, a leader in femtosecond laser technology, citing insurmountable opposition from the Federal Trade Commission (FTC). The collapse of the deal highlights increasing regulatory scrutiny over consolidation within the specialized medical device and ophthalmic surgery sectors.
JBS USA is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.